Question:
North Dakota Subscriber
Answer: You should be able to report a pair of infusion codes for the Remicade, and another code for the Benadryl administration. However, the brevity of the Benadryl infusion means you should opt for a non-infusion code.
Check out this coding advice, broken into two parts to make it more understandable:
Part 1 -- Remicade:
The total infusion time for the Remicade treatment was one hour and 42 minutes, meaning you can report the initial infusion code for the first hour plus an add-on code for the remaining 42 minutes. On the claim, report the following for the Remicade infusion:• 96413 (Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug) for the first hour.
• +96415 (... each additional hour [list separately in addition to code for primary procedure]) for the remaining 42 minutes.
• 555.1 (Regional enteritis; large intestine) linked to 96413 and 96415 to represent the patient's condition.
• J1745 (Injection, infliximab, 10 mg) x 20 to represent the Remicade supply.
(Only report 96415 when you are coding for at least 30 minutes of infusion time. So if a Remicade infusion lasts one hour and 20 minutes, for example, you would report only 96413.)
Part 2 -- Benadryl:
Remember, you can code separately for any antiemetics the internist provides the patient during a Remicade infusion.But since the Benadryl infusion was less than 15 minutes in duration, you should consider it a push and report +90775 (Therapeutic, prophylactic, or diagnostic injection [specify substance or drug]; each additional sequential intravenous push of a new substance/drug [list separately in addition to code for primary procedure]) with 555.1 attached.
Also, report J1200 (Injection, diphenhydramine HCl, up to 50 mg) for the Benadryl supply.